Search
Menu
Home
Sources
About
Contacts
TS-121
TS-121
is an
orally active
,
selective
vasopressin
V
1B
receptor antagonist
which is
under development
by
Taisho Pharmaceutical
for the
adjunctive treatment
of
major depressive disorder
. As of
May 2017
, it is in
phase II
clinical trials
for this
indication
.